Alecensa 150 MG capsule UU 240S
Ended Awarded Last action
- Contract number
- SPE2DR26FHCY1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,045
Award facts
- Contract value 100% obligated
- $13,045.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,045.19 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, indicating the award was made through full and open competition. The delivery will be performed at DMS Pharmaceutical Group's Park Ridge facility, supporting the Defense Logistics Agency's pharmaceutical supply chain operations.
This delivery order is issued under DMS Pharmaceutical Group's recently awarded Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to supply pharmaceutical products, biologics, and medical consumables to support Department of Defense military healthcare facilities globally. As a prime vendor contractor under this program, DMS Pharmaceutical Group is positioned to fulfill diverse pharmaceutical requirements across the federal military medical system through firm fixed-price delivery orders for recurring medical supply needs.
Quick answers
Who was awarded contract SPE2DR26FHCY1?
SPE2DR26FHCY1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FHCY1 worth?
The government has obligated $13,045 on SPE2DR26FHCY1.
Is contract SPE2DR26FHCY1 an order under another contract?
Yes. SPE2DR26FHCY1 is a delivery order under SPE2DR25D9207, an indefinite delivery contract.
Was contract SPE2DR26FHCY1 competed?
The extent of competition for SPE2DR26FHCY1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award